Tag: dova pharmaceuticals

2017 is turning out to be a good year for life sciences companies looking to go public.  To date, 36 companies have completed a successful initial public offering (IPO). While unimpressive compared to the 70 companies that went public at the height of the industry’s last IPO window (2014), it is a significant uptick over…